Invention Application
- Patent Title: HETEROCYCLIC CARBOXYLIC ACID ESTER DERIVATIVE
- Patent Title (中): 杂环羧酸酯衍生物
-
Application No.: US14098774Application Date: 2013-12-06
-
Publication No.: US20140094489A1Publication Date: 2014-04-03
- Inventor: Tamotsu SUZUKI , Takahiro KOSHIBA , Munetaka TOKUMASU , Koji OHSUMI
- Applicant: AJINOMOTO CO., INC.
- Applicant Address: JP Chuo-ku
- Assignee: AJINOMOTO CO., INC.
- Current Assignee: AJINOMOTO CO., INC.
- Current Assignee Address: JP Chuo-ku
- Priority: JP2011-127700 20110607
- Main IPC: C07D495/04
- IPC: C07D495/04 ; C07D333/38 ; C07D409/06 ; C07D417/06 ; C07D405/06 ; C07D307/68
Abstract:
The present invention provides a blood glucose elevation inhibitor having a serine protease inhibitory action, which is a novel therapeutic or prophylactic agent for obesity. A compound represented by the following formula (I) wherein each symbol is as described in the specification, or a pharmaceutically acceptable salt thereof.
Public/Granted literature
- US09346821B2 Heterocyclic carboxylic acid ester derivative Public/Granted day:2016-05-24
Information query
